Modification of tight junction structure and permeability by nutritional means

Annals of the New York Academy of Sciences

Volumn 1165, Issue , 2009, Pages 99-112

  Mullin, James M ^a,b   Skrovanek, Sonja M ^c   Valenzano, Mary Carmen ^a  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b LANKENAU HOSPITAL   (United States)

^c PRINCETON UNIVERSITY   (United States)

Author keywords

Caloric restriction; Claudin; Diet; LLC PK1; Mannitol; Methionine; Occludin; Paracellular; Sirtuin; Tight junction

Indexed keywords

CLAUDIN; CYSTEINE; CYSTINE; MEMBRANE PROTEIN; METHIONINE;

ARTICLE; CALORIC RESTRICTION; CELL CULTURE; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE RESISTANCE; CULTURE MEDIUM; ELECTRIC RESISTANCE; EPITHELIUM CELL; HUMAN; KIDNEY EPITHELIUM; LIFESPAN; LONGEVITY; NONHUMAN; NUTRITIONAL SUPPORT; TIGHT JUNCTION; TIGHT JUNCTION BARRIER FUNCTION;

EID: 67249142645     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04028.x     Document Type: Article

References (118)

1. Weindruch, R. et al. 1986. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J. Nutr. 116: 641-654.
2. Orentreich, N. et al. 1993. Low methionine inges-tion by rats extends life span. J. Nutr. 123: 269-274.
3. Zimmerman, J.A. et al. 2003. Nutritional control of aging. Exp. Gerontol. 38: 47-52.
4. Miller, R.A. et al. 2005. Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-1 and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell. 4(3): 119-125.
5. Richie, J.P., Jr. et al. 1994. Methionine restriction increases blood glutathione and longevity in F344 rats. FASEB J. 8: 1302.
6. Tisdale, M.J. 1980. Effect of methionine deprivation on methylation and synthesis of macromolecules. Br. J. Cancer 42: 121-128.
7. Kokkinakis, D.M. 2006. Methionine-stress: A pleiotropic approach in enhancing the efficacy of chemotherapy. Cancer Lett. 233: 195-207.
8. Cellarier, E. et al. 2003. Methionine dependency and cancer treatment. Cancer Treatment Rev. 29: 489-499.
9. Komninou, D. et al. 2006. Methionine restriction inhibits colon carcinogenesis. Nutr. Cancer 54: 202-208.
10. Thivat, E. et al. 2007. A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer. Anticancer Res. 27: 2779-2783.
11. Lu, S. et al. 2002. Methionine restriction induces apoptosis of prostate cancer cells via the c-Jun Nterminal kinase-mediated signaling pathway. Cancer Lett. 179: 51-58.
12. Fu, Y.M. et al. 2008. Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells. J. Cell Physiol.
13. Fu, Y.M. et al. 2004. Specific amino acid restriction inhibits attachment and spreading of human melanoma via modulation of the integrin/focal adhesion kinase pathway and actin cytoskeleton remodeling. Clin. Exp. Metastasis 21: 587-598.
14. Richie, J., Jr. et al. 2004. Tissue glutathione and cysteine levels in methionine-restricted rats. Nutrition 20: 800-805.
15. Pamplona, R. & G. Barja. 2006. Mitochondrial oxidative stress, aging and caloric restriction: The protein and methionine connection. BBA-Bioenergetics 1757: 496-508.
16. Caro, P. et al. 2008. Forty percent and eighty percent methionine restriction decrease mitochondrial ROS generation and oxidative stress in rat liver. Biogerontology 9(3): 183-196.
17. Dilova, I., E. Easlon & S.J. Lin. 2007. Calorie restriction and the nutrient sensing signaling pathways. Cell. Mol. Life Sci. (CMLS) 64: 752-767.
18. Pallas, M. et al. 2008. Modulation of sirtuins: new targets for antiageing. Recent Patents CNS Drug Discov. 3: 61-69.
19. Loenen, W.A. 2006. S-adenosylmethionine: jack of all trades and master of everything? Biochem. Soc. Trans. 34: 330-333.
20. Dvorak, A. & G. Dickersin. 1980. Crohn's disease: transmission electron microscopic studies. I. Barrier function. Possible changes related to alterations of cell coat, mucous coat, epithelial cells, and Paneth cells. Hum. Pathol. 11(5 Suppl): 561-571.
21. Farhadi, A. et al. 2003. Intestinal barrier: an interface between health and disease. J. Gastroenterol. Hepatol. 18: 479-497.
22. Podolsky, D.K. 1999. Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am. J. Physiol. 277: G495-499.
23. Baumgart, D. & A. Dignass. 2002. Intestinal barrier function. Curr. Opin. Clin. Nutr. Metab. Care 5: 685-694.
24. Schulzke, J.D., M. Fromm & U. Hegel. 1986. Epithelial and subepithelial resistance of rat large intestine: segmental differences, effect of stripping, time course, and action of aldosterone. Pflugers Arch. 407: 632-637.
25. Fromm, M., J.D. Schulzke & U. Hegel. 1985. Epithelial and subepithelial contributions to transmural electrical resistance of intact rat jejunum, in vitro. Pflugers Arch. 405: 400-402.
26. Groot, J., H. Albus & R. Bakker. 1981. Analysis of the ouabain-induced increase in transepithelial electrical resistance in the goldfish intestinal mucosa. Pflugers Arch. 392(1): 67-71.
27. Nagel, W., J.F. Garcia-Diaz & A. Essig. 1983. Cellular and paracellular conductance patterns in voltage-clamped frog skin. Prog. Clin. Biol. Res. 126: 221-231.
28. Finn, A. & L. Reuss. 1975. Effects of changes in the composition of the serosal solution on the electrical properties of the toad urinary bladder epithelium. J. Physiol. 250: 541-558.
29. Schneeberger, E.E. & R.D. Lynch. 1992. Structure, function, and regulation of cellular tight junctions. Am. J. Physiol. Lung Cell. Mol. Physiol. 262: L647-L661.
30. Anderson, J.M. & C.M. Van Itallie. 1999. Tight Junctions:closing in on the seal. Curr. Biol. 9: R922-924.
31. Tsukita, S. & M. Furuse. 2000. The structure and function of claudins, cell adhesion molecules at tight junctions. Ann. N. Y. Acad. Sci. 915: 129-135.
32. Gonzalez-Mariscal, L. et al. 2003. Tight junction proteins. Prog. Biophys. Mol. Biol. 81: 1-44.
33. Hopkins, A.M. et al. 2000. Modulation of tight junction function by G protein-coupled events. Adv. Drug Delv. Rev. 41: 329-340.
34. Lacaz-Vieira, F. 2000. Tight junction dynamics: oscillations and the role of protein kinase C. J. Membr. Biol. 178: 151-161.
35. Clarke, H., A.P. Soler & J.M. Mullin. 2000. Protein kinase C activation leads to dephosphorylation of occludin and tight junction permeability increase in LLC-PK1 epithelial cells sheets. J. Cell Sci. 113: 3187-3196.
36. Kottra, G. & C. Vank. 2003. The forskolin-induced opening of tight junctions in Xenopus gallbladder epithelium is mediated by protein kinase C. Cell Mol. Biol. (Noisy-le-grand) 49: 33-43.
37. Duffey, M. et al. 1981. Regulation of epithelial tight junction permeability by cyclic AMP. Nature 294: 451-453.
38. Ma, T.Y. et al. 2000. Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement. Microsc. Res. Tech. 51: 156-168.
39. Hecht, G. et al. 1996. Expression of the catalytic domain of myosin light chain kinase increases para-cellular permeability. Am. J. Physiol. 271: C1678-C1684.
40. Turner, J.R. et al. 1997. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am. J. Physiol. 273: C1378-1385.
41. Stuart, R.O. et al. 1994. Critical role for intracellular calcium in tight junction biogenesis. J. Cell Physiol. 159: 423-433.
42. Gonzalez-Mariscal, L. et al. 1990. Role of calcium in tight junction formation between epithelial cells. Am. J. Physiol. 259(6 Pt 1): C978-986.
43. Siliciano, J.D. & D.A. Goodenough. 1988. Localization of the tight junction protein, ZO-1, is modulated by extracellular calcium and cell-cell contact in Madin-Darby canine kidney epithelial cells. J. Cell Biol. 107: 2389-2399.
44. Denker, B.M. et al. 1996. Involvement of a heterotrimeric G protein alpha subunit in tight junction biogenesis. J. Biol. Chem. 271: 25750-25753.
45. Hirase, T. et al. 2001. Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms. J. Biol. Chem. 276: 10423-10431.
46. Jou, T., E. Schneeberger & W. Nelson. 1998. Structural and functional regulation of tight junctions by RhoA and Rac1 small GTPases. J. Cell Biol. 142: 101-115.
47. Meyer, T., C. Schwesinger & B. Denker. 2002. Zonula occludens-1 is a scaffolding protein for signaling molecules. Galpha(12) directly binds to the Src homology 3 domain and regulates paracellular permeability in epithelial cells. J. Biol. Chem. 277: 24855-24858.
48. Rubenstein, N.M. et al. 2003. Glucocorticoid downregulation of RhoA is required for the steroidinduced organization of the junctional complex and tight junction formation in rat mammary epithelial tumor cells. J. Biol. Chem. 278: 10353-10360.
49. Sawada, N. et al. 2003. Tight junctions and human diseases. Med. Electron. Microsc. 36: 147-156.
50. Jinguji, Y. & H. Ishikawa. 1992. Electron microscopic observations on the maintenance of the tight junction during cell division in the epithelium of the mouse small intestine. Cell Struct. Funct. 17: 27-37.
51. Soler, A.P., K.V. Laughlin & J.M. Mullin. 1993. Effects of epidermal growth factor versus phorbol ester on kidney epithelial (LLC-PK1) tight junction permeability and cell division. Exp. Cell Res. 207: 398-406.
52. Peralta Soler, A. et al. 1996. Tissue remodeling during tumor necrosis factor-induced apoptosis in LLCPK1 renal epithelial cells. Am. J. Physiol. 270: F869-F879.
53. Kojima, T. et al. 2001. Occludin and claudin-1 concentrate in the midbody of immortalized mouse hepatocytes during cell division. J. Histochem. Cytochem. 49: 333-340.
54. Madara, J. 1990. Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J. Membr. Biol. 116: 177-184.
55. Florian, P. et al. 2002. Single-cell epithelial defects close rapidly by an actinomyosin purse string mechanism with functional tight junctions. J. Physiol. 545(Pt 2): 485-499.
56. Bojarski, C. et al. 2000. Apoptosis and intestinal barrier function. Ann. N. Y. Acad. Sci. 915: 270-274.
57. Bojarski, C. et al. 2001. Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J. Physiol. 535: 541-552.
58. Holman, G. & R. Naftalin. 1979. Fluid movements across rabbit ileum coupled to passive paracellular ion movements. J. Physiol. 290: 351-366.
59. Fasano, A. et al. 1991. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc. Natl. Acad. Sci. USA 88: 5242-5246.
60. Fasano, A. et al. 2000. A newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355: 1518-1519.
61. Berkes, J. et al. 2003. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52: 439-451.
62. Clayburgh, D., L. Shen & J. Turner. 2004. A porous defense: the leaky epithelial barrier in intestinal disease. Lab. Invest. 84: 282-291.
63. Hofman, P. 2003. Pathological interactions of bacteria and toxins with the gastrointestinal epithelial tight junctions and/or the zonula adherens: an update. Cell Mol. Biol. (Noisy-le-grand) 49: 65-75.
64. Sears, C.L. 2000. Molecular physiology and pathophysiology of tight junctions V. assault of the tight junction by enteric pathogens. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G1129-1134.
65. Balkovetz, D.F. & J. Katz. 2003. Bacterial invasion by a paracellular route: divide and conquer. Microbes. Infect. 5: 613-619.
66. Philpott, D.J. et al. 1998. Signal transduction pathways involved in enterohemmorrhagic Escherichia coli-induced alterations in T84 epithelial permeability. Infect. Immun. 66: 1680-1687.
67. Obiso, R.J., Jr., A.O. Azghani & T.D. Wilkins. 1997. The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect. Immun. 65: 1431-1439.
68. Gogarten, W. et al. 1994. Effect of acute Yersinia enterocolitica infection on intestinal barrier function in the mouse. Scand. J. Gastroenterol. 29: 814-819.
69. Singh, U. et al. 2000. CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin. J. Biol. Chem. 275: 18407-18417.
70. Wu, Z., P. Nybom & K.E. Magnusson. 2000. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell Microbiol. 2: 11-17.
71. Chen, M., C. Pothoulakis & J. LaMont. 2002. Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 coloncytes exposed to Clostridium difficile toxin A. J. Biol. Chem. 277: 4247-4254.
72. Nusrat, A. et al. 2001. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect. Immun. 69: 1329-1336.
73. Dickman, K.G. et al. 2000. Rotavirus alters paracellular permeability and energy metabolism in caco-2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G757-G766.
74. MacIntyre, A. et al. 2002. Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells. FEMS Microbiol. Lett. 217: 167-172.
75. Chen, S. et al. 2003. Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J. Med. Microbiol. 52(Pt 11): 961-970.
76. Terres, A.M. et al. 1998. Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators. Infect. Immun. 66: 2943-2950.
77. Suzuki, K. et al. 2002. SS1 Helicobacter pylori disrupts the paracellular barrier of the gastric mucosa and leads to neutrophilic gastritis in mice. Virchows Arch. 440: 318-324.
78. Meggs, W. et al. 1996. Nasal pathology and ultrastructure in patients with chronic airway inflammation (RADS and RUDS) following an irritant exposure. J. Toxicol. Clin. Toxicol. 34: 383-396.
79. Wan, H. et al. 2001. The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of Dermatophagoides pteronyssinus. Clin. Exp. Allergy 31: 279-294.
80. Goldblum, S.E. & W.L. Sun. 1990. Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro. Am. J. Physiol. 258: L57-67.
81. Mullin, J.M. & K.V. Snock. 1990. The effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res. 50: 2172-2176.
82. Schmitz, H. et al. 1999. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J. Cell Sci. 112: 137-146.
83. Gitter, A. et al. 2000. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J. 14: 1749-1753.
84. Bojarski, C. et al. 2000. Apoptosis and intestinal barrier function. Ann. N. Y. Acad. Sci. 915: 270-274.
85. Rodriguez, P. et al. 1995. Tumour necrosis factoralpha induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers. Cytokine 7: 441-448.
86. Madsen, K. et al. 1997. Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroent. 113: 151-159.
87. Gardner, T.W. 1995. Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy. Trans. Am. Ophthalmol. Soc. 93: 583-621.
88. Caldwell, R.B. & S.M. Slapnick. 1992. Freezefracture and lanthanum studies of the retinal mi-crovasculature in diabetic rats. Invest. Ophthalmol. Vis. Sci. 33: 1610-1619.
89. Rossi, F. et al. 1991. De novo synthesis of diacylglycerol from glucose. A new pathway of signal transduction in human neutrophils stimulated during phagocytosis of beta-glucan particles. J. Biol. Chem. 266: 8034-8038.
90. Antonetti, D. et al. 1998. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decrease occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47: 19953-19959.
91. Barber, A. & D. Antonetti. 2003. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats. Invest. Ophthalmol. Vis. Sci. 44: 5410-5416.
92. Antcliff, R. & J. Marshall. 1999. The pathogenesis of edema in diabetic maculopathy. Semin. Ophthalmol. 14: 223-232.
93. Antonetti, D. et al. 1999. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J. Biol. Chem. 274: 23463-23467.
94. Chehade, J., M. Haas & A. Mooradian. 2002. Diabetes-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression. Neurochem. Res. 27: 249-252.
95. Martinez-Palomo, A. 1970. Ultrastructural modifactions of intercellular junctions. In Vitro 6: 15-20.
96. Posalaky, Z. & D. McGinley. 1984. Occluding junctions in an epithelioid mesothelioma: a freezefracture study. Ultrastruct. Pathol. 6: 177-183.
97. Alroy, J. 1979. Ultrastructure of canine urinary bladder carcinoma. Vet. Pathol. 16: 693-701.
98. Robenek, H. et al. 1981. Structure and function of the junctional complement of spontaneous and transplanted muring mammary carcinomas. J. Submicrosc. Cytol. 13: 347-363.
99. Kerjaschki, D. et al. 1979. The structure of tight junctions in human thyroid tumors. A systematic freeze-fracture study. Am. J. Pathol. 96: 207-225.
100. Polak-Charcon, S., J. Shoham & Y. Ben-Shaul. 1980. Tight junctions of epithelial cells of human fetal hindgut, normal colon and colon adenocarcinoma. J. Natl. Cancer Inst. 65: 53-57.
101. Aoyagi, K. et al. 2000. Morphological change in the MNNG-treated rat gastric mucosa. Kurume Med. J. 47: 31-36.
102. Saito, T. 1984. Ultrastructural changes on the junctional complexes in the human urinary bladder carcinoma by thin sectioning and freeze fracture. J. Clin. Electron. Micros. 17: 201-209.
103. Swift, J.G., T.M. Mukherjee & R. Rowland. 1983. Intercellular junctions in hepatocellular carcinoma. J. Submicrosc. Cytol. 15: 799-810.
104. Davies, R. et al. 1989. Detection of the cancerprone colon, using transepithelial impedance analysis. Arch. Surg. 124: 480-484.
105. Gonzalez-Correa, C. et al. 2003. Low frequency electrical bioimpedance for the detection of inflammation and dysplasia in Barrett's oesophagus. Physiol. Meas. 24: 291-296.
106. Tobioka, H. et al. 2004. Sawada, N. Occludin expression decreases with the progression of human endometrial carcinoma. Hum. Pathol. 35: 159-164.
107. Tobioka, H. et al. 2002. Polarized distribution of carcinoembryonic antigen is associated with a tight junction molecule in human colorectal adenocarcinoma. J. Pathol. 198: 207-212.
108. Busch, C. et al. 2002. Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum. Pathol. 33: 290-298.
109. Kimura, Y. et al. 1997. Expression of occludin, tight-junction-associated protein, in human digestive tract. Am. J. Pathol. 151: 45-54.
110. Marzioni, D. et al. 2001. Expression of ZO-1 and occludin in normal human placenta and in hy-datidiform moles. Mol. Hum. Reprod. 7(3): 279-285.
111. Davies, R. 2002. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J. Anat. 200: 639-646.
112. Papadopoulos, M.C. et al. 2001. Occludin expression in microvessels of neoplastic and non-neoplastic human brain. Neuropathol. Appl. Neurobiol. 27: 384-395.
113. Wang, W., W.L. Dentler & R.T. Borchardt. 2001. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am. J. Physiol. Heart Circ. Physiol. 280: H434-440.
114. Liebner, S. et al. 2000. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol. (Berl.) 100: 323-331.
115. Kramer, F. et al. 2000. Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum. Genet. 107: 249-256.
116. Miwa, N. et al. 2000. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol. Res. 12: 469-476.
117. Skrovanek, S., M.C. Valenzano & J.M. Mullin. 2007. Restriction of sulfur-containing amino acids alters claudin composition and improves tight junction barrier function. Am. J. Physiol. Regul. Integr. Comp. Physiol. Epub ahead of print.
118. Mullin, J.M. et al. 1980. Sugar transport in the LLC-PK1 renal epithelial cell line: similarity to mammalian kidney and the influence of cell density. J. Cell Physiol. 10 4: 375-389.